by Advize Admin | Oct 3, 2019 | Fraud, FWA, Healthcare
Retired OIG Special Agent and Advize’s Director of Litigation & FWA Support will be stepping in each week to examine current fraud trends from the lens of an investigator. Stay tuned for weekly insights, updates, and information on healthcare’s most expensive...
by Advize Admin | Sep 27, 2019 | Fraud, FWA, Healthcare
Retired OIG Special Agent and Advize’s Director of Litigation & FWA Support will be stepping in each week to examine current fraud trends from the lens of an investigator. Stay tuned for weekly insights, updates, and information on healthcare’s most expensive...
by Advize Admin | Sep 27, 2019 | Fraud, FWA, Healthcare
Advize Health’s very own Eric Rubenstein has been featured in a recent Law360 article after participating in a series of discussions on healthcare fraud, waste, and abuse across the NY Metropolitan area this week. Rubenstein spoke candidly about his experience...
by Advize Admin | Sep 5, 2019 | Compliance, Fraud, Healthcare
Retired OIG Special Agent and Advize’s Director of Litigation & FWA Support will be stepping in each week to examine current fraud trends from the lens of an investigator. Stay tuned for weekly insights, updates, and information on healthcare’s most expensive...
by Advize Admin | Aug 29, 2019 | OIG Files
Retired OIG Special Agent and Advize’s Director of Litigation & FWA Support will be stepping in each week to examine current fraud trends from the lens of an investigator. Stay tuned for weekly insights, updates, and information on healthcare’s most expensive...
by Advize Admin | Aug 15, 2019 | Compliance, Fraud, FWA, Healthcare
Federal healthcare fraud recoveries totaled upwards of $2.3B in the 2018 fiscal year. This staggering sum is proof enough that healthcare fraud is here to stay as an unfortunate reality of the industry. Providers, patients, and insurers alike have all been complicit...
by Advize Admin | Aug 7, 2019 | Fraud, Healthcare
Recently, the State of New Jersey, Division of Consumer Affairs (the department that administers, among other things, the Prescription Monitoring Program [PMP]), reclassified a drug known as Gabapentin. In reclassifying the drug, it is now considered a scheduled drug...
by Advize Admin | Jul 30, 2019 | Fraud, Healthcare
Over the last several weeks, I’ve been discussing some ways that unscrupulous providers take advantage of the system for their personal gain. But what about those underhanded providers who not only take advantage of the system itself, with things like services not...
by Advize Admin | Jul 24, 2019 | Fraud, FWA, Healthcare
Retired OIG Special Agent and Advize’s Director of Litigation & FWA Support will be stepping in each week to examine current fraud trends from the lens of an investigator. Stay tuned for weekly insights, updates, and information on healthcare’s most expensive...
by Advize Admin | Jul 5, 2019 | Fraud, FWA, Healthcare
Retired OIG Special Agent and Advize’s Director of Litigation & FWA Support will be stepping in each week to examine current fraud trends from the lens of an investigator. Stay tuned for weekly insights, updates, and information on healthcare’s most expensive...
Recent Comments